medical news from internet

Friday, June 5, 2020

Adenovirus Type 5 Vectored COVID-19 Vaccine Tolerable, Immunogenic in Phase 1 Study 

 

Antiviral Merimepodib to Be Investigated in Phase 2 Trial for COVID-19

Bamr Mann bombaymann@gmail.com at 9:26 AM
Share

No comments:

Post a Comment

‹
›
Home
View web version
Powered by Blogger.